TAF9A inhibitors are chemical compounds that specifically target and inhibit TAF9A, a subunit of the Transcription Factor IID (TFIID) complex, which is crucial for the initiation of gene transcription by RNA polymerase II. TAF9A plays a key role in the assembly and stabilization of the TFIID complex, as well as in mediating interactions between other transcriptional co-factors and regulatory elements within gene promoters. This protein is involved in recognizing and binding to specific DNA sequences, thereby facilitating the recruitment of RNA polymerase II to initiate the transcription of genes. By inhibiting TAF9A, these compounds interfere with the proper assembly of the transcriptional machinery, potentially leading to altered gene expression profiles.
Researchers use TAF9A inhibitors to study the function of this protein in transcription regulation and to explore how its inhibition impacts the overall transcriptional activity within the cell. Inhibition of TAF9A can provide insights into the specific genes and pathways that depend on the proper functioning of TAF9A and the broader TFIID complex. By blocking the activity of TAF9A, scientists can dissect the molecular mechanisms that control the assembly of transcriptional complexes and the precise roles of individual TAF subunits in gene expression. These inhibitors are important tools for understanding how TAF9A contributes to the regulation of transcription initiation and how disruptions in this process may affect cellular function, chromatin structure, and regulatory networks involved in gene expression. Through the use of TAF9A inhibitors, researchers gain deeper insight into the fundamental processes that govern transcription and its intricate regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $210.00 $242.00 $1434.00 | 2 | |
Histone deacetylase inhibitor. While it increases histone acetylation, it can alter the interaction dynamics of TAF9 with TFIID. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
HDAC inhibitor that may indirectly affect the chromatin state and thereby hinder TAF9's involvement in transcription initiation. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $311.00 | ||
Inhibits CDK9, a factor for RNA polymerase II function, potentially suppressing TAF9-mediated transcription initiation. | ||||||
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
Inhibits EZH2 and EZH1, potentially altering chromatin structure and impeding TAF9's function in transcription. | ||||||
A-485 | 1889279-16-6 | sc-507493 | 5 mg | $275.00 | ||
Inhibitor of p300/CBP histone acetyltransferase activity, potentially hindering TAF9 interaction dynamics with TFIID. | ||||||
JIB 04 | 199596-05-9 | sc-397040 | 20 mg | $177.00 | ||
Pan-selective Jumonji histone demethylase inhibitor, potentially altering the chromatin state and TAF9's function. | ||||||
EX 527 | 49843-98-3 | sc-203044 | 5 mg | $85.00 | 32 | |
SIRT1 inhibitor. By affecting histone deacetylation, it can indirectly modulate the function of TAF9 within the TFIID complex. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
Inhibitor of G9a/GLP, impacting histone methylation states and potentially TAF9's role in transcription initiation. | ||||||